Product Information
- Product Code: RSV-19C20
- Quantity: 20
- Sample: Nasopharyngeal swab / Nasal aspirate
- Format: Cassette
- Time-to-Result: 15 minutes
- Storage Condition: 36-86°F (2-30°C)
- Test Principle: Lateral Flow Immunoassay
Contents
- 20 Individually packaged test devices
- 20 Sterile Nasopharyngeal swabs
- 20 Specimen processing tubes
- 20 Sterile normal saline vials
- 20 Extraction tubes
- 40 Disposable pipettes
- 1 R1 (Extraction reagent solution)
- 1 PC (Positive control reagent)
- 1 NC (Negative control reagent)
- 1 Instructions for use
The Rapid Response™ RSV Test Cassette is a rapid test for the qualitative detection of respiratory syncytial virus (RSV) antigens directly from nasopharyngeal swab and nasal aspirate specimens in children under 6 years and adults over the age of 60. The test is intended for use as an aid in the rapid laboratory diagnosis of acute respiratory syncytial virus infection in patients with symptoms consistent with RSV infection.
- CLIA Waived. For in vitro diagnostic use. For prescription use only.
- Detects RSV Nucleoproteins from a single-swab sample, the test detects RSV fusion (F) protein.
- Improved patient care with results in just 15 minutes this test enables swift decision-making within the same visit.
- Cost-effective alternative to laboratory methods and requires no specialized training.
- Complete kit that includes all the materials needed for testing nasopharyngeal samples including test cassettes, saline vials, extraction reagent solution, controls, extraction tubes, nasopharyngeal swabs, pipettes, and specimen processing tubes.
Respiratory syncytial virus (RSV) is a highly contagious, acute, viral infection of the respiratory tract. The causative agent is a single stranded (negative strand) RNA virus of the Paramyxoviridae
family. RSV is now recognized as the leading cause of hospitalization of children during the first year of life. It is also the major viral cause of nosocomial illness in children already hospitalized for other reasons. Half of all infants become infected during their first year of life. Virtually all have been infected by their second year.1 Infection involving the lower respiratory tract carries an associated mortality rate of 0.5%, especially in premature infants or infants and children with underlying lung disease.
Respiratory Syncytial Virus (RSV) can be spread through droplets containing the virus when someone coughs or sneezes. It can also live on surfaces, on hands and clothing. RSV is a major cause of respiratory illness in young children, affecting the lungs and breathing passages. In adults rsv symptoms may manifest as a common cold, such as a stuffy or runny nose, sore throat, mild headache, cough, fever, and a general feeling of being ill. But in premature babies and children with compromised immune system, lung or heart diseases, RSV can cause severe illnesses.2
References
1 Respiratory Syncytial Virus Activity — United States 2000-01 MMWR, CDC January 18, 2002.
2 Glezen, WP; Taber, LH; Frank, AL; Kasel, JA (1986). “Risk of primary infection and reinfection with respiratory syncytial virus”. American journal of diseases of children (1960). 140(6): 543–6. doi:10.1001/archpedi.1986.02140200053026.PMID 3706232.
3. Centers for Disease Control and Prevention. (2023). RSV Symptoms. www.cdc.gov/rsv/about/symptoms.html
Disclaimers
- Please note that certain products may only be available in specific regions; kindly consult with a sales representative for further information regarding product availability.
- The information provided on this website is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare professional regarding any medical concerns or conditions.
- Our products are intended for use as specified in the product documentation. It is important to carefully read and follow all instructions provided with the product.